Thursday, February 11, 2016 2:50:14 PM
ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
On February 11, 2016 the company signed an exclusive Software Licensing Agreement ("SLA") with Augicom S.A., ("Augicom") to distribute the Company's CreateApp platform in the Euro-Zone except Russia, Turkey, Armenia and Azerbaijan.
The SLA calls for a US$20 monthly fee per user of the CreateApp platform deployed by Augicom.
The focus is on the European SMB market. As of early 2015, there were approximately 30 million SMB's in the EU.
Augicom S.A., is a corporation organized and existing under the laws of the Swiss Confederation.
http://www.augicom.ch/
Augicom S.A., (Augicom) holds a public telecommunication license from OFCOM, the Swiss Federal Office for Communication. Augicom is an active supplier of telecommunication voice/data minutes and has significant partnerships with major European operators including Orange, Colt Telecom, Deutsche Telekom and many others.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(a) Financial Statements of Businesses Acquired: None
(b) Pro-Forma Financial Statements: None
(c) Exhibits:
Exhibit No.
Description
10.1
Software Licensing Agreement with Augicom S.A., dated February 11, 2016
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
WEYLAND TECH INC.
Dated: February 11, 2016
By:
/s/ Brent Y. Suen
Name:
Brent Y. Suen
Title:
President & CEO
Balance, Symmetry, Patience & Prosperity.
Do not make your decision to buy, hold or sell based on my opinions. Blessings all!
Recent LGIQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:43:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 09:08:29 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/13/2023 09:30:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 08:11:35 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/25/2023 09:04:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 09:03:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/10/2023 10:48:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 04:28:19 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 09/29/2023 09:20:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:32:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 05:05:22 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:57:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2023 01:51:06 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM